176 related articles for article (PubMed ID: 16673695)
21. Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression.
Bingham KS; Whyte EM; Meyers BS; Mulsant BH; Rothschild AJ; Banerjee S; Flint AJ;
Am J Geriatr Psychiatry; 2015 Dec; 23(12):1270-1275. PubMed ID: 26560512
[TBL] [Abstract][Full Text] [Related]
22. Measuring treatment response in psychotic depression: the Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account.
Østergaard SD; Meyers BS; Flint AJ; Mulsant BH; Whyte EM; Ulbricht CM; Bech P; Rothschild AJ;
J Affect Disord; 2014 May; 160():68-73. PubMed ID: 24439830
[TBL] [Abstract][Full Text] [Related]
23. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Al-Adwani A
Can J Psychiatry; 2005 Nov; 50(13):877; author reply 877-8. PubMed ID: 16483124
[No Abstract] [Full Text] [Related]
24. Regarding "Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs".
Koesters M; Becker T; Weinmann S
Biol Psychiatry; 2009 Sep; 66(5):e7; authour reply e9-10. PubMed ID: 19520365
[No Abstract] [Full Text] [Related]
25. Nowhere patients.
Tomba E
Psychother Psychosom; 2012; 81(2):69-72. PubMed ID: 22261819
[No Abstract] [Full Text] [Related]
26. Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studies.
Nelson JC; Mankoski R; Baker RA; Carlson BX; Eudicone JM; Pikalov A; Tran QV; Berman RM
J Affect Disord; 2010 Jan; 120(1-3):133-40. PubMed ID: 19656577
[TBL] [Abstract][Full Text] [Related]
27. Successful duloxetine use to prevent venlafaxine withdrawal symptoms.
Hsiao MC; Liu CY
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):576. PubMed ID: 17889418
[No Abstract] [Full Text] [Related]
28. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.
Matthews JD; Bottonari KA; Polania LM; Mischoulon D; Dording CM; Irvin R; Fava M
J Clin Psychiatry; 2002 Dec; 63(12):1164-70. PubMed ID: 12523877
[TBL] [Abstract][Full Text] [Related]
29. Venlafaxine: Successful treatment in impulsive disorders.
Camardese G; Picello A; Bria P
Psychiatry Clin Neurosci; 2008 Apr; 62(2):241-2. PubMed ID: 18412851
[No Abstract] [Full Text] [Related]
30. The review by Weinmann and colleagues.
Freemantle N
Psychopharmacology (Berl); 2008 Jul; 199(1):131-2; author reply 133-4. PubMed ID: 18504557
[No Abstract] [Full Text] [Related]
31. SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study.
Davies SJ; Mulsant BH; Flint AJ; Meyers BS; Rothschild AJ; Whyte EM; Kirshner MM; Sorisio D; Pollock BG; Bies RR;
Hum Psychopharmacol; 2016 May; 31(3):252-5. PubMed ID: 27060853
[TBL] [Abstract][Full Text] [Related]
32. Why Is There No Food and Drug Administration-Approved Medication for Major Depression With Psychotic Features?
Rothschild AJ
J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):359-361. PubMed ID: 34166258
[No Abstract] [Full Text] [Related]
33. Addition of olanzapine for treatment-resistant depression.
Pitchot W; Ansseau M
Am J Psychiatry; 2001 Oct; 158(10):1737-8. PubMed ID: 11579017
[No Abstract] [Full Text] [Related]
34. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
Brent DA
Depress Anxiety; 2009; 26(10):871-4. PubMed ID: 19798756
[No Abstract] [Full Text] [Related]
35. [Effective treatment of depressive disorder with psychotic symptoms by olanzapine combination therapy].
Schmitt A; Braus DF
Dtsch Med Wochenschr; 2000 Dec; 125(50):1526-9. PubMed ID: 11190762
[TBL] [Abstract][Full Text] [Related]
36. Combined oral venlafaxine and intravenous clomipramine-A: successful temporary response in a patient with extremely refractory depression.
Fountoulakis KN; Iacovides A; St Kaprinis G
Can J Psychiatry; 2004 Jan; 49(1):73-4. PubMed ID: 14763683
[No Abstract] [Full Text] [Related]
37. Does venlafaxine maintenance therapy prevent depression recurrences or drug discontinuation reactions?
Jureidini J; Mintzes B
J Clin Psychiatry; 2008 May; 69(5):865-6; author reply 866. PubMed ID: 18681767
[No Abstract] [Full Text] [Related]
38. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.
Whyte EM; Basinski J; Farhi P; Dew MA; Begley A; Mulsant BH; Reynolds CF
J Clin Psychiatry; 2004 Dec; 65(12):1634-41. PubMed ID: 15641868
[TBL] [Abstract][Full Text] [Related]
39. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
Fava M; Schaefer K; Huang H; Wilson A; Iosifescu DV; Mischoulon D; Wessel TC
J Clin Psychiatry; 2011 Apr; 72(4):473-9. PubMed ID: 21208574
[TBL] [Abstract][Full Text] [Related]
40. A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD).
Meyers BS; Flint AJ; Rothschild AJ; Mulsant BH; Whyte EM; Peasley-Miklus C; Papademetriou E; Leon AC; Heo M;
Arch Gen Psychiatry; 2009 Aug; 66(8):838-47. PubMed ID: 19652123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
